# Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects

> **NCT03988530** · PHASE3 · COMPLETED · sponsor: **Repurposed Therapeutics, Inc.** · enrollment: 98 (actual)

## Conditions studied

- Motion Sickness

## Interventions

- **DRUG:** Scopolamine
- **OTHER:** Placebo Nasal Gel

## Key facts

- **NCT ID:** NCT03988530
- **Lead sponsor:** Repurposed Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-07
- **Primary completion:** 2020-11-23
- **Final completion:** 2020-11-23
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03988530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03988530, "Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03988530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*